Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Ansaldo STS Spa (OTC: ASDOF).

Full DD Report for ASDOF

You must become a subscriber to view this report.


Recent News from (OTC: ASDOF)

It's Official: General Electric Secures EU Approval For Alstom Deal
General Electric (NYSE: GE ) has now officially won European Union approval for its transaction to buy Alstom SA (OTCPK: ALSMY ) energy assets. This approval came after over a year of scrutiny over concerns regarding competition in the European turbine markets, higher prices and possible job...
Source: SeekingAlpha
Date: September, 09 2015 18:42
Wall Street Breakfast: Airbus Clinches Largest-Ever Plane Order
IndiGo, India's biggest airline, has firmed up an order to buy as many as 250 Airbus ( OTCPK:EADSY ) A320neos, handing the European planemaker its largest-ever deal by number of aircraft. The $26.5B purchase helps extend Airbus's lead over arch-rival Boeing (NYSE: BA ) for the fast-g...
Source: SeekingAlpha
Date: August, 17 2015 06:39
Alstom jumps on expectations of GE deal
Alstom ( OTCPK:ALSMY ) shares are riding high, following Friday's report that suggested GE will secure EU approval for its proposed 12.4B acquisition of the French firm's power unit. More news on: Alstom ADR, Ansaldo STS Spa, Alstom, Merger & acquisition news, Stocks on the move R...
Source: SeekingAlpha
Date: August, 17 2015 05:35

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-06-21N/A14.9157N/AN/A0
2018-06-20N/A14.9157N/AN/A0
2018-06-19N/A14.9157N/AN/A0
2018-06-18N/A14.9157N/AN/A0
2018-06-14N/A14.9157N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2017-02-08200200100.0000Short
2016-03-09100100100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ASDOF.


About Ansaldo STS Spa (OTC: ASDOF)

Logo for Ansaldo STS Spa (OTC: ASDOF)

Ansaldo STS is a leading technology company that operates in the global Railway amp Mass Transit Transportation Systems business and provides rail traffic management, planning, train control and signalling systems and services. It also acts as lead contractor and turnkey provider on major projects worldwide.

 

 

 

Current Management

  • Sergio De Luca / CEO
  • Alberto Milvio / CFO
  • Andrea Razeto / VP, Investor Rel.

Current Share Structure

  • Market Cap: $2,600,000,000 - 03/14/2018
  • Issue and Outstanding: 200,000,000 - 12/31/2015

 



Daily Technical Chart for (OTC: ASDOF)

Daily Technical Chart for (OTC: ASDOF)


Stay tuned for daily updates and more on (OTC: ASDOF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: ASDOF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ASDOF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of ASDOF and does not buy, sell, or trade any shares of ASDOF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/